CS177135B2 - - Google Patents

Info

Publication number
CS177135B2
CS177135B2 CS4342A CS434273A CS177135B2 CS 177135 B2 CS177135 B2 CS 177135B2 CS 4342 A CS4342 A CS 4342A CS 434273 A CS434273 A CS 434273A CS 177135 B2 CS177135 B2 CS 177135B2
Authority
CS
Czechoslovakia
Application number
CS4342A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of CS177135B2 publication Critical patent/CS177135B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/12—1,4-Dioxanes; Hydrogenated 1,4-dioxanes not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CS4342A 1972-06-15 1973-06-15 CS177135B2 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2567272 1972-06-15

Publications (1)

Publication Number Publication Date
CS177135B2 true CS177135B2 (cs) 1977-07-29

Family

ID=11217412

Family Applications (1)

Application Number Title Priority Date Filing Date
CS4342A CS177135B2 (cs) 1972-06-15 1973-06-15

Country Status (6)

Country Link
JP (1) JPS5767556A (cs)
AT (1) AT340608B (cs)
BE (1) BE800953A (cs)
CS (1) CS177135B2 (cs)
SU (1) SU632301A3 (cs)
ZA (1) ZA733967B (cs)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7429669B2 (en) * 2006-06-20 2008-09-30 Allergan, Inc. Therapeutic compounds

Also Published As

Publication number Publication date
ZA733967B (en) 1974-11-27
JPS5767556A (en) 1982-04-24
SU632301A3 (ru) 1978-11-05
ATA528973A (de) 1977-04-15
BE800953A (fr) 1973-10-01
AT340608B (de) 1977-12-27

Similar Documents

Publication Publication Date Title
JPS5144138B2 (cs)
FR2192648A5 (cs)
JPS5733703B2 (cs)
JPS4917227U (cs)
JPS5112024B2 (cs)
JPS5548446B2 (cs)
JPS4918480A (cs)
JPS5314213B2 (cs)
JPS49289U (cs)
JPS494125A (cs)
CS177135B2 (cs)
JPS4893789A (cs)
JPS5023519Y2 (cs)
JPS52321Y2 (cs)
CS156896B1 (cs)
JPS4891733U (cs)
BG18442A1 (cs)
CH562773A5 (cs)
CH603647A5 (cs)
CH602761A5 (cs)
CH602547A5 (cs)
CH596378B5 (cs)
BE794494A (cs)
BG18198A1 (cs)
CH591567A5 (cs)